ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q1SCImago #4,462Gold OA

Advanced Nanobiomed Research

Acronym:advnanobiomedres
•
Identifier (ISSN):2699-9307(Print)
•
Publisher:Wiley-VCH, Germany
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
4.8↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Advanced Nanobiomed Research

WoS Q2
24573.42023420244.420254.82026
Annual Impact Factor Metric
Current (2026):4.8
Scopus SJR & RankScopus Q1
1.058
#4,462

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
31

31 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate2.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
55articles/year
100% Gold OA•59.82% Original Research

Aims & Scope

Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.

Topics Covered (Recognized by AI)
Biology72.3%Chemistry66.2%Medicine62.2%Materials science57.6%Genetics56.8%Engineering52.5%Nanotechnology51.1%Biochemistry48.9%Physics43.9%Organic chemistry43.2%Internal medicine38.5%Chemical engineering34.5%Computer science32.4%Quantum mechanics31.3%Composite material21.9%Cell biology20.5%Immunology20.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ENGINEERING, BIOMEDICAL

Q2
Rank42/130
IndexESCI
JCRESCI2026

MATERIALS SCIENCE, BIOMATERIALS

Q2
Rank24/58
IndexESCI
JCRESCI2026

NANOSCIENCE & NANOTECHNOLOGY

Q2
Rank68/148
IndexESCI
JCIESCI2026

ENGINEERING, BIOMEDICAL

Q3
Rank76/130
IndexESCI
JCIESCI2026

MATERIALS SCIENCE, BIOMATERIALS

Q3
Rank39/58
IndexESCI
JCIESCI2026

NANOSCIENCE & NANOTECHNOLOGY

Q3
Rank83/148
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

7 year
2026Latest
IF4.8
Articles / Year55
Total Citations7
2025
IF4.4
Articles / Year136
Total Citations204
2024
IF4
Articles / Year108
Total Citations682
2023
IF3.4
Articles / Year121
Total Citations928
2022
IF—
Articles / Year115
Total Citations1,505

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,462Scopus Q1SCImago Profile
Scopus Coverage:2021-2026
Scopus Broad Areas:EngineeringImmunology and MicrobiologyMaterials ScienceMedicine
Scopus Citation Rank (SJR)Q1
1.058

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.20

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,333 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,432
3-Year Documents251
Citable Documents248

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Applied Microbiology and BiotechnologyQ1
BiomaterialsQ1
Engineering (miscellaneous)Q1
Medicine (miscellaneous)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENGINEERING, BIOMEDICAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Advanced Nanobiomed Research (acronym: advnanobiomedres, ISSN: 2699-9307) is a peer-reviewed international scholarly journal in the field of nanomedicine, published by Wiley-VCH, Germany in Germany. The periodical holds a Journal Impact Factor (JIF) of 4.80, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.058 (Q1), an H-index of 31.

The journal enforces rigorous peer evaluation with an annual output of approximately 55 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,333 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-VCH, Germany
Publication Language
English
Frequency
Periodic
Indexing & Databases
PubMed
Editorial Address
Postfach 10 11 61 69451 Weinheim Germany

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b3ba7639-bc74-406f-9cbd-3028a5b86e77
Database Updated: 2026-10-01